Use of Elagolix in Gynaecology

Hugh S Taylor

doi:10.1016/j.jogc.2018.01.004

Use of Elagolix in Gynaecology

Hugh S Taylor

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC · 2018 · vol. 40(7) , pp. 931–934 · doi:10.1016/j.jogc.2018.01.004 · PMID:29921430 · W2808712755

review OA: closed CC0 ⤵ 7 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper discusses the use of elagolix, a gonadotropin-releasing hormone antagonist, in the management of endometriosis-associated pain and uterine fibroids.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715

MeSH descriptors

Endometriosis Hydrocarbons, Fluorinated Pyrimidines Receptors, LHRH Administration, Oral Endometriosis Female Gynecology Humans Hydrocarbons, Fluorinated Hydrocarbons, Fluorinated Pyrimidines Pyrimidines Receptors, LHRH

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (22)

Clinical diagnosis of endometriosis and optimal medical therapy via openalex
Comparing the Efficacy of Surgery and MedicalTherapy for Pain Management in Endometriosis:A Systematic Review and Meta-analysis via openalex
Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study via openalex
Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis: Effects on Bone Mineral Density via openalex
Elagolix, an oral gonadotropin-releasing hormone antagonist, for the management of endometriosis-associated pain: safety and efficacy results from two double-blind, randomized, placebo-controlled studies via openalex
Elagolix Treatment for Endometriosis-Associated Pain: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study via openalex
Endometriosis via openalex
Endometriosis: Diagnosis and Management via openalex
Epidemiology of Endometriosis: via openalex
Estrogen-progestins and progestins for the management of endometriosis via openalex
Long-term effect of elagolix on bone mineral density: results from two phase 3 extension studies in women with endometriosis-associated pain via openalex
Long-term safety and efficacy of elagolix treatment in women with endometriosis-associated pain: primary results from two phase 3 extension studies via openalex
Management of Endometriosis: Toward Value-Based, Cost-Effective, Affordable Care via openalex
New developments in the medical treatment of endometriosis via openalex
Suppression of Gonadotropins and Estradiol in Premenopausal Women by Oral Administration of the Nonpeptide Gonadotropin-Releasing Hormone Antagonist Elagolix via openalex
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist: Results from a Phase 2, Randomized Controlled Study via openalex
W2085320423 via openalex
W2195249017 via openalex
W2276856939 via openalex
W2610244466 via openalex
W2130203785 via openalex

Cited by (7)

Source provenance

europepmc: last seen: 2026-06-04T01:30:01.192114+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:19:43.094626+00:00

License: CC0 · commercial use OK

[1] Clinical diagnosis of endometriosis and optimal medical therapy via openalex

[2] Comparing the Efficacy of Surgery and MedicalTherapy for Pain Management in Endometriosis:A Systematic Review and Meta-analysis via openalex

[3] Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study via openalex

[4] Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis: Effects on Bone Mineral Density via openalex

[5] Elagolix, an oral gonadotropin-releasing hormone antagonist, for the management of endometriosis-associated pain: safety and efficacy results from two double-blind, randomized, placebo-controlled studies via openalex

[6] Elagolix Treatment for Endometriosis-Associated Pain: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study via openalex

[7] Endometriosis via openalex

[8] Endometriosis: Diagnosis and Management via openalex

[9] Epidemiology of Endometriosis: via openalex

[10] Estrogen-progestins and progestins for the management of endometriosis via openalex

[11] Long-term effect of elagolix on bone mineral density: results from two phase 3 extension studies in women with endometriosis-associated pain via openalex

[12] Long-term safety and efficacy of elagolix treatment in women with endometriosis-associated pain: primary results from two phase 3 extension studies via openalex

[13] Management of Endometriosis: Toward Value-Based, Cost-Effective, Affordable Care via openalex

[14] New developments in the medical treatment of endometriosis via openalex

[15] Suppression of Gonadotropins and Estradiol in Premenopausal Women by Oral Administration of the Nonpeptide Gonadotropin-Releasing Hormone Antagonist Elagolix via openalex

[16] Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex

[17] Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist: Results from a Phase 2, Randomized Controlled Study via openalex

[18] W2085320423 via openalex

[19] W2195249017 via openalex

[20] W2276856939 via openalex

[21] W2610244466 via openalex

[22] W2130203785 via openalex